Riskpilot← Back to searchSign inGet full accessPharmaway Invest ApS
APSActiveCVR 38585126Fredskovvej 12Activities of holding companies · NACE 6421Est. 2017— employees
Revenue 2024
DKK -29K
+84% vs 2023
EBITDA margin
100.0%
-84% vs 2023
Equity ratio
99.5%
Financial strength
Net profit 2024
DKK -39K
-97% vs 2023
| Revenue | DKK -29K | +84% |
| EBITDA | DKK -29K | -84% |
| Net profit | DKK -39K | -97% |
| Total assets | DKK 48,2M | +0% |
| Equity | DKK 48M | +0% |
| Employees | — | — |
Legal name
Pharmaway Invest ApS
CVR number
38585126
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
21. april 2017
Share capital
DKK 64.454
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede direktion.
Company purpose
Selskabets formål er at eje kapitalandele i andre selskaber samt anden virksomhed, der efter direktionens skøn er forbundet dermed.
Address
Fredskovvej 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -23 | -22 | -14 | -16 | -29 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -23 | -22 | -14 | -16 | -29 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -23 | -22 | -14 | -16 | -29 |
| Net financials | -2 | -3 | -4 | -4 | -10 |
| Profit before tax | -25 | -25 | -18 | -20 | -39 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -25 | -25 | -18 | -20 | -39 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 36.266 | 48.244 | 48.243 | 48.242 | 48.241 |
| Equity | 36.089 | 48.064 | 48.047 | 48.027 | 47.988 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 177 | 180 | 196 | 215 | 252 |
| Total debt | 177 | 180 | 196 | 215 | 252 |
EBITDA margin
-2875000.0%
This company
15.8%
Market median
-18196303% vs market
20202024
Equity ratio
99.5%
This company
38.2%
Market median
+160% vs market
20202024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
20202024
Net profit margin
-3858300.0%
This company
8.1%
Market median
-47633433% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NE Management | Management | 2017 |
SR Founder | Founder | 2017 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2017 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2017 | |
| Company | 5–9.99% | 5–9.99% | 2017 | |
| Company | 5–9.99% | 5–9.99% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ebbelykke ApS
Pharmaway Invest ApS Board members of Pharmaway Invest ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Ebbe Ebbesen | Management | 0 companies |
| Steen Rode | Founder | 0 companies |